In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine

[Image: see text] Actively targeted theranostic nanomedicine may be the key for future personalized cancer management. Although numerous types of theranostic nanoparticles have been developed in the past decade for cancer treatment, challenges still exist in the engineering of biocompatible theranos...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Feng, Hong, Hao, Goel, Shreya, Graves, Stephen A., Orbay, Hakan, Ehlerding, Emily B., Shi, Sixiang, Theuer, Charles P., Nickles, Robert J., Cai, Weibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414921/
https://www.ncbi.nlm.nih.gov/pubmed/25843647
http://dx.doi.org/10.1021/nn507241v

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414921/
https://www.ncbi.nlm.nih.gov/pubmed/25843647
http://dx.doi.org/10.1021/nn507241v

Ejemplares similares